Details for Patent: 9,493,582
✉ Email this page to a colleague
Summary for Patent: 9,493,582
Title: | Alkylated cyclodextrin compositions and processes for preparing and using the same |
Abstract: | The present invention related to low-chloride alkylated cyclodextrin compositions, along with processes for preparing and using the same. The processes of the present invention provide alkylated cyclodextrins with low levels of drug-degrading agents and chloride. |
Inventor(s): | Antle; Vincent D. (Olathe, KS), Lopes; Alvaro (Loures, PT), Monteiro; Daniel (Loures, PT) |
Assignee: | Cydex Pharmaceuticals, Inc. (San Diego, CA) |
Application Number: | 14/381,568 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,493,582 |
Patent Claim Types: see list of patent claims | Use; Composition; Process; Formulation; |
Drugs Protected by US Patent 9,493,582
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Melinta | BAXDELA | delafloxacin meglumine | POWDER;INTRAVENOUS | 208611-001 | Jun 19, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Acrotech Biopharma | EVOMELA | melphalan hydrochloride | POWDER;INTRAVENOUS | 207155-001 | Mar 10, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Onyx Pharms Amgen | KYPROLIS | carfilzomib | POWDER;INTRAVENOUS | 202714-003 | Jun 7, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Onyx Pharms Amgen | KYPROLIS | carfilzomib | POWDER;INTRAVENOUS | 202714-002 | Jun 3, 2016 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Onyx Pharms Amgen | KYPROLIS | carfilzomib | POWDER;INTRAVENOUS | 202714-001 | Jul 20, 2012 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Lundbeck Pharms Llc | CARNEXIV | carbamazepine | SOLUTION;INTRAVENOUS | 206030-001 | Oct 7, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Merck Sharp Dohme | NOXAFIL | posaconazole | SOLUTION;INTRAVENOUS | 205596-001 | Mar 13, 2014 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,493,582
PCT Information | |||
PCT Filed | February 27, 2013 | PCT Application Number: | PCT/US2013/028094 |
PCT Publication Date: | September 06, 2013 | PCT Publication Number: | WO2013/130666 |
International Family Members for US Patent 9,493,582
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013226073 | ⤷ Try a Trial | |||
Australia | 2016210707 | ⤷ Try a Trial | |||
Canada | 2865950 | ⤷ Try a Trial | |||
China | 104704007 | ⤷ Try a Trial | |||
China | 110066351 | ⤷ Try a Trial | |||
European Patent Office | 2748205 | ⤷ Try a Trial | |||
Hong Kong | 1211311 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |